| 1993 |
STX4 (syntaxin-4) was identified as a member of the syntaxin family of vesicular transport receptors; it contains a carboxy-terminal hydrophobic membrane anchor, is expressed broadly across tissues, and when expressed in COS cells is targeted to specific subcellular compartments distinct from other syntaxin family members, implicating it as a receptor for intracellular transport vesicles at a defined target membrane. |
Molecular cloning, COS-cell heterologous expression, subcellular fractionation, microinjection |
Cell |
High |
7690687
|
| 1996 |
STX4 interacts with SNAP-23 (a ubiquitously expressed SNAP-25 homolog) in non-neuronal tissues; the SNAP-23/syntaxin complex serves as a binding site for the general membrane fusion machinery, implicating STX4/SNAP-23 in vesicle docking and fusion in non-neuronal cells. |
Yeast two-hybrid, in vitro binding assay with recombinant proteins |
The Journal of Biological Chemistry |
High |
8663154
|
| 1997 |
Munc-18c specifically binds syntaxin-4 (but not syntaxin-1A, -2, or -3 for Munc-18c) at the plasma membrane of 3T3-L1 adipocytes and inhibits syntaxin-4 interaction with VAMP-2; insulin stimulates movement of syntaxin-4 and Munc-18c from an intracellular fraction; microinjection of syntaxin-4 antibody blocks insulin-dependent GLUT4 recruitment to the cell surface, establishing the Munc-18c/syntaxin-4/VAMP-2 complex as required for insulin-stimulated GLUT4 vesicle docking/fusion. |
In vitro recombinant protein binding assay, subcellular fractionation, antibody microinjection into 3T3-L1 adipocytes, immunofluorescence |
The Journal of Biological Chemistry |
High |
9045631
|
| 2004 |
STX4 facilitates Ca2+-regulated lysosomal exocytosis by forming a SNARE complex with SNAP-23 and the lysosomal v-SNARE TI-VAMP/VAMP7 at the plasma membrane; Ca2+-dependent interaction of synaptotagmin VII C2A domain with SNAP-23 is facilitated by syntaxin-4; SDS-resistant ternary SNARE complexes containing SNAP-23, syntaxin-4, and TI-VAMP7 form after cytosolic Ca2+ elevation; SNARE domain of syntaxin-4 inhibits lysosomal exocytosis when overexpressed. |
Co-immunoprecipitation from cell lysates, SDS-PAGE of SDS-resistant SNARE complexes, dominant-negative SNARE domain overexpression, lysosomal exocytosis assay |
The Journal of Biological Chemistry |
High |
14993220
|
| 2008 |
The C-terminal domain of Synip directly interacts with STX4; in the basal state this interaction prevents VAMP2 from binding STX4; insulin induces dissociation of Synip from STX4, allowing VAMP2 to interact with STX4 to form the SNARE complex and promote GLUT4 vesicle fusion; the N-terminal 1-28 residues of STX4 are dispensable for Synip interaction. |
Co-expression in E. coli using dual-vector system (pGEX6p-1/pET28a), co-purification, in vitro binding assay, deletion mutagenesis |
Biochemical and Biophysical Research Communications |
Medium |
18439908
|
| 2010 |
STX4 defines a postsynaptic exocytic microdomain adjacent to the PSD in dendritic spines; during elevated synaptic activity, large AMPA receptor-containing recycling compartments fuse preferentially at STX4-enriched plasma membrane microdomains; disruption of STX4 (dominant-negative or knockdown) impairs spine exocytosis and long-term potentiation (LTP) at hippocampal synapses, establishing STX4 as the t-SNARE mediating postsynaptic membrane fusion for synaptic plasticity. |
Live-cell TIRF microscopy, dominant-negative STX4 expression, siRNA knockdown, LTP electrophysiology in hippocampal slices, immunofluorescence localization |
Cell |
High |
20434989
|
| 2011 |
The SNARE complex VAMP3/STX4/SNAP23 mediates polarized exocytosis of recycling endosome membrane during macrophage spreading and migration on fibronectin; STX4/SNAP23 accumulate at sites of membrane expansion where VAMP3-positive vesicles fuse; knockdown of VAMP3 disrupts podosome ring superstructures and polarized podosome localisation, reducing persistent macrophage migration. |
siRNA knockdown, immunofluorescence, live-cell imaging, cell spreading/migration assays on fibronectin |
Experimental Cell Research |
Medium |
21586284
|
| 2011 |
STX4 is present in phagosomes of dendritic cells and serves as the plasma membrane SNARE partner for the ER-ERGIC SNARE Sec22b; Sec22b-STX4 pairing mediates recruitment of ER-resident proteins to phagosomes and is required for antigen cross-presentation; depletion of Sec22b impairs ER protein recruitment to phagosomes and reduces antigen export to the cytosol. |
Co-immunoprecipitation, subcellular fractionation, siRNA knockdown in DCs, cross-presentation functional assay, immunofluorescence |
Cell |
High |
22153078
|
| 2022 |
Skeletal muscle-specific transgenic enrichment of STX4 (skmSTX4tg) reverses high-fat diet-induced insulin resistance in mice without altering body weight; electron microscopy localizes STX4 at or proximal to the mitochondrial membrane in muscle; STX4 enrichment prevents HFD-induced mitochondrial fragmentation through a direct STX4-Drp1 interaction and elevated AMPK-mediated phosphorylation of Drp1 at S637 (favoring fusion), demonstrating that STX4 acts not only at the plasma membrane but also regulates mitochondrial dynamics. |
Transgenic mouse model (skmSTX4tg), glucose/insulin tolerance tests, electron microscopy, Co-immunoprecipitation (STX4-Drp1), phospho-Drp1 S637 immunoblot, mitochondrial morphology quantification |
Nature Communications |
High |
35058456
|
| 2022 |
STX4 is required for normal vertebrate cardiac conduction and vesicular transport; loss of stx4 in zebrafish (CRISPR/Cas9 knockout) causes linearized hearts, bradycardia, and reduced docking of Vamp2+ vesicles to the cardiomyocyte sarcolemma; optical mapping and pharmacological Ca2+ modulation reveal that stx4 mutants have reduced L-type Ca2+ channel modulation; human STX4 R240W is a hypomorphic variant associated with dilated cardiomyopathy. |
CRISPR/Cas9 zebrafish knockout, optical mapping of embryonic hearts, live imaging of Vamp2+ vesicles, pharmacological Ca2+ channel modulation, transgenic overexpression of STX4R241W |
HGG Advances |
Medium |
35599850
|
| 2023 |
CRISPR/Cas9 knockout of STX4 in murine APC lines had very limited effects on cross-presentation of PLGA microsphere-encapsulated antigen or synthetic long peptides, suggesting SNARE redundancy in the cytosolic pathway of cross-presentation and questioning the essential role of the Sec22b/STX4 axis in this specific context. |
CRISPR/Cas9 gene knockout in murine APC lines, cross-presentation functional assay, flow cytometry |
Journal of Immunology |
Medium |
37638825
|
| 2025 |
STX4 is indispensable for mitochondrial homeostasis in skeletal muscle: inducible skeletal muscle-specific STX4 knockout (skmSTX4-iKO) causes insulin resistance, reduced energy expenditure, impaired mitochondrial oxygen consumption, mitochondrial fragmentation (oxidative fibers) or swelling (glycolytic fibers), and decreased electron transport chain complex abundance; STX4 depletion also reduces mitochondrial biogenesis genes (PGC1-α, NRF1, Tfam) and impairs PINK1/PARKIN-dependent mitophagy, as demonstrated by live mt-Keima biosensor imaging. |
Inducible skeletal muscle-specific knockout mice, siRNA knockdown in L6 myotubes, mitochondrial oxygen consumption rate, electron microscopy, [U-13C]glucose isotope tracing, mt-Keima live-cell mitophagy imaging, immunoblotting for ETC complexes and mitophagy markers |
Journal of Cachexia, Sarcopenia and Muscle |
High |
41214862
|
| 2025 |
STX4 (together with SNAP23) participates as a Q-SNARE in secretory autophagy-mediated exocytosis of the Alzheimer-associated ubiquitin variant UBB+1; disruption of STX4 impairs fusion of UBB+1-containing autophagosome-like vesicles with the plasma membrane, reducing UBB+1 secretion. |
SNARE knockdown/knockout, UBB+1 secretion assay, vesicle-plasma membrane fusion assessment |
bioRxivpreprint |
Low |
bio_10.1101_2024.12.31.630908
|
| 2025 |
STX4 silencing in ovarian cancer cell lines (SK-OV-3, CAOV-3) via shRNA reduces proliferation, migration, and invasion and decreases E-cadherin, MMP2, and CCND1 levels, implicating STX4 in regulating EMT and cell cycle progression in cancer cells; in vivo tumor xenograft models confirmed reduced tumorigenicity. |
shRNA knockdown, CCK-8 proliferation assay, Transwell migration/invasion assay, scratch assay, immunoblotting for EMT/MMP/cyclin markers, xenograft mouse model |
Journal of Ovarian Research |
Low |
40483481
|